AI assistant
Sending…
Zalaris — Director's Dealing 2021
Jun 10, 2021
3795_dirs_2021-06-10_0e6149ae-75be-4a7c-89b6-b58f6d8fa512.pdf
Director's Dealing
Open in viewerOpens in your device viewer
{# SEO P0-1: filing HTML is rendered server-side so Googlebot
sees the full text without executing JS or following an
iframe to a Disallow'd CDN path. The content has already
been sanitized through filings.seo.sanitize_filing_html. #}
| 1 | Details of the person discharging managerial responsibilities/person closely associated | |||
|---|---|---|---|---|
| a) | Name | AHAG Vermögensverwaltung GmbH | ||
| 2 | Reason for the notification | |||
| a) | Position/status | The notification concerns a legal person closely associated with a Primary Insider: Harald Goetsch, Executive Vice President Central Europe in Zalaris ASA. |
||
| b) | Initial | Initial notification | ||
| notification/Amendment | ||||
| 3 | Details of issuer | |||
| a) | Name | Zalaris ASA | ||
| b) | LEI | 549300XBITM62HH7HW18 | ||
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type | |||
| of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||
| a) | Description of the financial | Nature of the instrument: Shares | ||
| instrument, type of | Instrument identification code (ISIN): NO 001 070 8910 | |||
| instrument Identification code |
||||
| b) | Nature of the transaction | Sale of shares. | ||
| Transaction is not linked to the exercise of a share option programme. | ||||
| c) | Price(s) and volume(s) | Price(s) | Volume(s) | |
| 60 | 200 000 | |||
| Transaction currency in NOK | ||||
| d) | Aggregated information | Price per share: 60 Volume: 200 000 |
||
| — Aggregated volume |
||||
| — Price |
Total sum of shares sold: NOK 12 000 000 | |||
| e) | Date of the transaction | 2021-06-10 | ||
| f) | Place of the transaction | XOSL – Oslo Børs |
More from Zalaris
Regulatory Filings
2026
May 8
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 4
Regulatory Filings
2026
May 4
Regulatory Filings
2026
May 4
Regulatory Filings
2026
Apr 30
M&A Activity
2026
Apr 29
Investor Presentation
2026
Apr 28
Interim / Quarterly Report
2026
Apr 28